Tonix Pharmaceuticals Holding Corp reports results for the quarter ended in June - Earnings Summary

Tonix Pharmaceuticals Holding

17/08/2024 06:25

* Tonix Pharmaceuticals Holding Corp  TNXP.OQ  reported a
quarterly adjusted loss of $19.28​​ per share for the quarter
ended in June, higher than the same quarter last year, when the
company reported EPS of $-85.76.  The mean expectation of
three analysts for the quarter was for a loss of $3.27 per
share. Wall Street expected results to range from $-7.36
to $-1.18 per share.
    * Revenue was $2.21 million​; analysts expected $3.50
million. 
    * Tonix Pharmaceuticals Holding Corp shares had fallen
by 34.5%
this quarter and lost 96.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 58.5%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Tonix
Pharmaceuticals Holding Corp is $11.00 
This summary was machine generated from LSEG data August 17 at
05:24 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -3.27          -19.28         Missed
 Mar. 31 2024      -12.48         -5.76          Beat
 Dec. 31 2023      -52.59         -27.52         Beat
 Sep. 30 2023      -47.68         -58.56         Missed